Terray Therapeutics is the latest firm to score a significant heap of cash in order to develop an artificial intelligence (AI)-based drug discovery and development platform, and it is armed with what it calls the world’s largest chemistry dataset, along with partnerships with Bristol Myers Squibb Company and Calico Life Sciences.
Key Takeaways
- Terray Therapeutics closed a $120m series B funding round, led by Bedford Ridge Capital and NVIDIA’s NVentures venture capital arm.
The AI-fueled biotech, based in Monrovia, CA, said 17 October that it had closed a $120m series B financing, which...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?